NCT04649775View on ClinicalTrials.gov

AirFLO2 Treatment for Hypoxia and/or Tachypnea in Patients With COVID-19

NATerminatedINTERVENTIONAL

Enrollment

11

Participants

Timeline

Start Date

April 9, 2021

Primary Completion Date

November 8, 2021

Study Completion Date

November 8, 2021

Conditions

Corona Virus InfectionRespiratory RateHypoxiaCovid19

Interventions

DEVICE

AirFLO2

Mask device

Trial Locations (1)

27710

Duke University Health System, Durham

Sponsors

Lead Sponsor

Duke University

Collaborators (1)

All Listed Sponsors

collaborator

MEDEX

OTHER

lead

Duke University

OTHER

NCT04649775 - AirFLO2 Treatment for Hypoxia and/or Tachypnea in Patients With COVID-19 | Biotech Hunter | Biotech Hunter